GlassScriptPhysician profile
Craig Allen Eisentrout
NPI 1801980164
$16,626.73
in general payments reported to CMS, 2019-2025
36 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,472 · 2020: $11K · 2021: $982 · 2022: $919 · 2023: $1,536 · 2024: $203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000 · Food and Beverage: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
| Food and Beverage | $738.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,905.77 | 2019-2023 | Da Vinci Sp, Da Vinci Surgical System |
| Glaxosmithkline, LLC. | $698.86 | 2019-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $639.33 | 2019-2023 | Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $514.08 | 2019-2023 | Ofev, Stiolto Respimat |
| Genzyme Corporation | $332.58 | 2019-2024 | |
| Grifols USA, LLC | $126.73 | 2019-2023 | Prolastin-C Liquid |
| Tempus Ai, INC | $121.66 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $118.35 | 2021-2023 | Dupixent |
| Galvanize Therapeutics, INC | $116.19 | 2023 | Aliya System |
| Mylan Specialty L.P. | $111.54 | 2019-2024 | Yupelri |
| Sunovion Pharmaceuticals INC. | $82.68 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $81.42 | 2020-2023 | Glassia |
| Insmed, INC. | $61.80 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $60.25 | 2019-2022 | |
| Electromed, INC. | $56.19 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covis Pharma Gmbh | $53.12 | 2020-2022 | |
| Philips North America LLC | $46.60 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $44.75 | 2020-2024 | Keytruda |
| Mallinckrodt Hospital Products INC. | $43.75 | 2020-2021 | |
| Astellas Pharma US INC | $40.23 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $36.71 | 2019-2020 | |
| United Therapeutics Corporation | $33.48 | 2019-2021 | |
| Circassia INC. | $31.93 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $31.11 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $30.49 | 2020-2022 | |
| Pfizer INC. | $30.06 | 2019-2023 | |
| Novartis Pharmaceuticals Corporation | $28.69 | 2021-2022 | |
| Csl Behring | $27.30 | 2020 | |
| Paratek Pharmaceuticals, INC. | $26.44 | 2020 | |
| Gilead Sciences, INC. | $17.00 | 2021 | |
| Genentech USA, INC. | $16.02 | 2022 | |
| Mayne Pharma Commercial LLC | $14.32 | 2019 | |
| Shire North American Group INC | $13.40 | 2019 | |
| Portola Pharmaceuticals, LLC | $12.88 | 2019 | |
| Bio Products Laboratory USA, INC. | $10.98 | 2019 | |
| Acacia Pharma INC | $10.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Eisentrout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.